- Home
- SCI vs MRNA Comparison
SCI vs MRNA Comparison
Compare SCI & MRNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SCI
- MRNA
- Stock Information
- Founded
- SCI 1962
- MRNA 2010
- Country
- SCI United States
- MRNA United States
- Employees
- SCI N/A
- MRNA N/A
- Industry
- SCI Other Consumer Services
- MRNA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- SCI Consumer Discretionary
- MRNA Health Care
- Exchange
- SCI Nasdaq
- MRNA Nasdaq
- Market Cap
- SCI 11.3B
- MRNA 9.2B
- IPO Year
- SCI N/A
- MRNA 2018
- Fundamental
- Price
- SCI $79.78
- MRNA $24.62
- Analyst Decision
- SCI Strong Buy
- MRNA Hold
- Analyst Count
- SCI 3
- MRNA 15
- Target Price
- SCI $92.00
- MRNA $36.69
- AVG Volume (30 Days)
- SCI 961.2K
- MRNA 12.2M
- Earning Date
- SCI 10-29-2025
- MRNA 11-06-2025
- Dividend Yield
- SCI 1.61%
- MRNA N/A
- EPS Growth
- SCI 8.17
- MRNA N/A
- EPS
- SCI 3.71
- MRNA N/A
- Revenue
- SCI $4,290,729,999.00
- MRNA $2,232,000,000.00
- Revenue This Year
- SCI $4.10
- MRNA N/A
- Revenue Next Year
- SCI $3.40
- MRNA $10.38
- P/E Ratio
- SCI $21.45
- MRNA N/A
- Revenue Growth
- SCI 3.41
- MRNA N/A
- 52 Week Low
- SCI $71.75
- MRNA $23.04
- 52 Week High
- SCI $89.37
- MRNA $48.92
- Technical
- Relative Strength Index (RSI)
- SCI 42.83
- MRNA 45.38
- Support Level
- SCI $79.16
- MRNA $23.04
- Resistance Level
- SCI $81.25
- MRNA $27.10
- Average True Range (ATR)
- SCI 1.90
- MRNA 1.61
- MACD
- SCI -0.23
- MRNA -0.02
- Stochastic Oscillator
- SCI 29.19
- MRNA 26.54
About SCI Service Corporation International
Service Corp International is a personal services company that provides funeral and cemetery services and products from its locations throughout the United States and Canada. The company segments its operations into funeral service and cemetery business functions. At its funeral service locations, Service Corp. provides all professional services, facilities, vehicles, and merchandise related to funerals and cremations. Cemetery locations provide cemetery property, memorial markers, and graveyard services to customers. Service Corp. derives the majority of its revenue from its funeral services segment. Geographically, the company derives a majority of its revenue from the United States.
About MRNA Moderna Inc.
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 35 mRNA development candidates in clinical studies as of August 2025. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.